(Q34523575)

2 August 2017

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma (English)

1 reference

colorectal adenocarcinoma

2 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

29 October 2023

author name string

P. Seifert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1203840

29 October 2023

L. H. Baker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1203840

29 October 2023

M. L. Reed

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1203840

29 October 2023

V. K. Vaitkevicius

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1203840

29 October 2023

language of work or name

English

0 references

publication date

1 July 1975

1 reference

full work available at URL

2 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

29 October 2023

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

29 October 2023

1 reference

2 August 2017

36

1 reference

2 August 2017

123-128

1 reference

2 August 2017

1

1 reference

5-fluorouracil given once weekly: Comparison of intravenous and oral administration

2 August 2017

2

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

Is toxicity really necessary? I. The question

29 October 2023

4

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES

29 October 2023

7

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

29 October 2023

8

18

478

Curreri

1958

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

29 October 2023

9

19

935

Gold

1939

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

Time and vehicle studies of a safe and effective method for administration of 5-fluorouracil

29 October 2023

10

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

29 October 2023

11

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

29 October 2023

12

18

305

Heidelberger

1958

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks

29 October 2023

13

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

Treatment of cancer with weekly intravenous 5-fluorouracil.Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG)

29 October 2023

14

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

Treatment of metastatic colorectal carcinoma with 5-fluorouracil by mouth

29 October 2023

16

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

29 October 2023

20

32

2717

Moertel

1972

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

Clinical evaluation of cancer chemotherapy with 5-fluorouracil

29 October 2023

21

1 reference

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

https://api.crossref.org/works/10.1002/1097-0142(197507)36:1%3C123::AID-CNCR2820360108%3E3.0.CO;2-C

29 October 2023

Identifiers

10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO;2-C

1 reference

2 August 2017

1 reference